- Home
- SVA vs INM Comparison
SVA vs INM Comparison
Compare SVA & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVA
- INM
- Stock Information
- Founded
- SVA N/A
- INM 1981
- Country
- SVA
- INM Canada
- Employees
- SVA 3261
- INM N/A
- Industry
- SVA
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- SVA
- INM Health Care
- Exchange
- SVA NYSE
- INM Nasdaq
- Market Cap
- SVA N/A
- INM 3.2M
- IPO Year
- SVA N/A
- INM N/A
- Fundamental
- Price
- SVA $6.47
- INM $2.81
- Analyst Decision
- SVA
- INM
- Analyst Count
- SVA 0
- INM 0
- Target Price
- SVA N/A
- INM N/A
- AVG Volume (30 Days)
- SVA N/A
- INM 5.7M
- Earning Date
- SVA N/A
- INM 05-12-2025
- Dividend Yield
- SVA N/A
- INM N/A
- EPS Growth
- SVA N/A
- INM N/A
- EPS
- SVA N/A
- INM N/A
- Revenue
- SVA N/A
- INM $4,920,990.00
- Revenue This Year
- SVA N/A
- INM N/A
- Revenue Next Year
- SVA N/A
- INM N/A
- P/E Ratio
- SVA N/A
- INM N/A
- Revenue Growth
- SVA N/A
- INM N/A
- 52 Week Low
- SVA N/A
- INM $1.72
- 52 Week High
- SVA N/A
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- SVA N/A
- INM 45.23
- Support Level
- SVA N/A
- INM $2.69
- Resistance Level
- SVA N/A
- INM $2.97
- Average True Range (ATR)
- SVA 0.00
- INM 0.35
- MACD
- SVA 0.00
- INM -0.05
- Stochastic Oscillator
- SVA 0.00
- INM 1.41
About SVA SINOVAC BIOTECH LTD
Sinovac Biotech Ltd is a China-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including, without limitation, hepatitis A, hepatitis B, hand foot and mouth disease (HFMD) caused by EV71, seasonal influenza, H5N1 and H1N1 pandemic influenza, coronavirus, pneumococcus, poliomyelitis, varicella and mumps.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.